Number of biotech deals drops as equity balloons

Biotech Quarterly Venture
Innovative in science and medicine concept design. Photo courtesy of Natali_Mis/iStock/Getty Images
The number of venture deals in the biotechnology sector continued its downward decline in the first quarter of 2018 compared to the same period in the three previous years. Meanwhile, the amount of equity raised by biotech companies continued to ...

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

This content is available for Venture Capital subscribers only. Request a free trial to get access for a limited period

Venture Capital

Subscribe Now Request Trial

If you already have an active Venture Capital subscription, please sign in to view this article.